Jean-Philippe Loeffler

Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models.

J. Loeffler, L. Dupuis, Luc Dupuis, 2009, Current opinion in pharmacology.

Targeting CREB-binding protein (CBP) loss of function as a therapeutic strategy in neurological disorders.

J. Loeffler, C. Rouaux, Jean-Philippe Loeffler, 2004, Biochemical pharmacology.

Guidelines for preclinical animal research in ALS/MND: A consensus meeting

Albert C. Ludolph, Linda Greensmith, Heiko G. Niessen, 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Elevated levels of amyloid precursor protein in muscle of patients with amyotrophic lateral sclerosis and a mouse model of the disease

R. Prinjha, P. Soden, H. Koistinen, 2006, Muscle & nerve.

Cyclin-dependent Kinases Phosphorylate p73 at Threonine 86 in a Cell Cycle-dependent Manner and Negatively Regulate p73*

Yoichi Taya, Carol Prives, C. Prives, 2003, Journal of Biological Chemistry.

Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model.

Michael Primig, Vincent Meininger, Christa Niederhauser-Wiederkehr, 2008, Physiological genomics.

Transcriptional Activation of the Proopiomelanocortin Gene by Cyclic AMP-responsive Element Binding Protein

J. Loeffler, D. Lorang, Jean-Philippe Loeffler, 1998, Pituitary.

Impaired glucose tolerance in patients with amyotrophic lateral sclerosis

Lucette Lacomblez, Vincent Meininger, Dominique Simon, 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.